NYMTN Financials
Newest figures come from the 10-Q for Q1 FY2026, filed May 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NYMTN SEC filings page.
NYMTN (NYMTN) reported $601.9M in revenue for fiscal year 2025, up 50.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2025 restored profitability and cash generation, but a heavily liability-funded asset base makes financing conditions central to reported results.
Operating cash flow was$134M against net income of$149M in FY2025, a89.9% conversion rate that supports the quality of the reported rebound. With free cash flow of$126M and capital expenditures at6.1% of operating cash flow, the business currently converts earnings without heavy reinvestment.
The balance sheet is expanding faster than its owners' capital: assets grew
The profit recovery was not simply overhead compression: selling, general and administrative expense was
Financial Health Signals
We do not publish a peer-relative financial health score for NYMTN, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
NYMTN passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, NYMTN generates $0.90 in operating cash flow ($134.0M OCF vs $149.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
NYMTN earns $0.30 in operating income for every $1 of interest expense ($137.8M vs $452.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
NYMTN generated $172.1M in revenue in Q1 2026. This represents an increase of 32.6% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.
NYMTN's EBITDA was $91.3M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 109.5% from the same quarter a year earlier. Against the prior quarter it is up 48.1%.
NYMTN reported $48.6M in net income in Q1 2026. This represents an increase of 15.3% from the same quarter a year earlier. Against the prior quarter it is down 9.2%.
NYMTN earned $0.40 per diluted share (EPS) in Q1 2026. This represents an increase of 21.2% from the same quarter a year earlier.
Cash & Balance Sheet
NYMTN held $208.9M in cash against $669.5M in long-term debt as of Q1 2026.
NYMTN paid $0.23 per share in dividends in Q1 2026. This represents an increase of 15.0% from the same quarter a year earlier. It is unchanged from the prior quarter.
Not reported for Q1 2026.
Margins & Returns
NYMTN's operating margin was 50.4% in Q1 2026, reflecting core business profitability. This is up 21.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.4 percentage points.
NYMTN's net profit margin was 28.2% in Q1 2026, showing the share of revenue converted to profit. This is down 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.1 percentage points.
NYMTN's quarterly ROE was 3.3% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.
Not reported for Q1 2026.
Capital Allocation
NYMTN spent $5.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q1 2026.
Not reported for Q1 2026.
NYMTN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $172.1M+32.6% | $170.7M+44.3% | $160.6M+48.2% | $140.9M+55.2% | $129.7M+54.6% | $118.3M+50.1% | $108.4M+66.2% | $90.8M+57.8% |
| SG&A Expenses | $24.5M+97.3% | $25.1M+108.7% | $23.3M+95.5% | $11.8M+1.2% | $12.4M-4.9% | $12.0M+2.5% | $11.9M+1.0% | $11.6M-12.5% |
| Operating Income | $86.7M+130.0% | $56.3Mn/m | $39.5M-7.7% | $4.3Mn/m | $37.7Mn/m | -$31.8M-196.8% | $42.8Mn/m | -$23.7Mn/m |
| EBITDA | $91.3M+109.5% | $61.7Mn/m | $45.4M-10.8% | $10.2Mn/m | $43.6Mn/m | -$24.9M-163.7% | $50.9Mn/m | -$11.5Mn/m |
| Interest Expense | $123.7M+28.0% | $127.5M+39.3% | $124.0M+40.8% | $104.5M+45.6% | $96.6M+46.4% | $91.5M+47.7% | $88.1M+82.1% | $71.7M+69.2% |
| Income Tax | $159K-75.5% | -$44Kn/m | -$298K-112.8% | -$161K-147.1% | $648Kn/m | -$1.5M-1242.9% | $2.3Mn/m | $342Kn/m |
| Net Income | $48.6M+15.3% | $53.5Mn/m | $44.8M+4.6% | $8.5Mn/m | $42.2Mn/m | -$31.4M-174.9% | $42.8Mn/m | -$15.6Mn/m |
| EPS (Basic) | $0.41+24.2% | N/A | $0.360.0% | -$0.04n/m | $0.33 | N/A | $0.36n/m | -$0.29n/m |
| EPS (Diluted) | $0.40+21.2% | N/A | $0.360.0% | -$0.04n/m | $0.33 | N/A | $0.36n/m | -$0.29n/m |
| Diluted Shares (Avg) | 92M+1.1% | N/A | 92M+1.1% | 90M-0.7% | 91M | N/A | 91M-0.4% | 91M-0.2% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
NYMTN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.8B+27.9% | $12.6B+37.1% | $12.4B+39.3% | $10.6B+28.2% | $10.0B+34.3% | $9.2B+24.5% | $8.9B+28.4% | $8.2B+31.1% |
| Cash & Equivalents | $208.9M+18.0% | $210.3M+25.6% | $185.3M-5.0% | $160.4M-31.9% | $177.1M-22.0% | $167.4M-10.5% | $195.1M-14.6% | $235.5M+1.3% |
| Goodwill | $22.4M | $22.4Mn/m | $22.4M | N/A | N/A | $0 | N/A | N/A |
| Total Liabilities | $11.3B+32.0% | $11.2B+43.6% | $11.0B+47.9% | $9.2B+35.4% | $8.6B+44.8% | $7.8B+35.2% | $7.4B+39.7% | $6.8B+49.5% |
| Long-Term Debt | $669.5M+2.3% | $735.8M+28.4% | $766.6M+9.6% | $653.0M-18.4% | $654.4M-34.6% | $573.2M-38.6% | $699.4M+28.5% | $800.7M+47.0% |
| Total Equity | $1.5B+3.9% | $1.4B+2.3% | $1.4B-3.7% | $1.4B-3.5% | $1.4B-5.6% | $1.4B-11.7% | $1.4B-8.3% | $1.4B-15.3% |
| Retained Earnings | -$1.4Bn/m | -$1.4Bn/m | -$1.4Bn/m | -$1.4Bn/m | -$1.4Bn/m | -$1.4Bn/m | -$1.4Bn/m | -$1.4Bn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.
NYMTN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$16.7M-164.7% | $62.1M+113.2% | $6.9Mn/m | $39.2Mn/m | $25.8Mn/m | $29.1M+122.6% | -$922K-103.2% | -$993Kn/m |
| Depreciation & Amortization | $4.6M-21.6% | $5.4M-22.0% | $5.9M-27.0% | $5.9M-51.5% | $5.9M-53.1% | $6.9M+10.1% | $8.1M+31.1% | $12.2M+99.7% |
| Stock-Based Compensation | $175K-79.7% | N/A | N/A | N/A | $861K | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | $3.5M-38.4% | $7.6M-35.5% | $7.6M-49.0% |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | $25.7M+243.5% | -$8.6M-151.8% | -$8.6Mn/m |
| Investing Cash Flow | -$67.0Mn/m | -$148.1Mn/m | -$1.6Bn/m | -$360.0Mn/m | -$794.2Mn/m | -$584.3Mn/m | -$834.1Mn/m | -$572.1Mn/m |
| Financing Cash Flow | $106.7M-85.0% | $130.6M-76.3% | $1.6B+102.6% | $313.5M-43.1% | $713.8M+118.1% | $552.2M+53.6% | $798.8M+8.0% | $550.5M+344.6% |
| Dividends Paid | $21.4M+16.0% | $20.8M+14.8% | $18.1M-0.2% | $18.2M-0.4% | $18.5M-9.8% | $18.1M-33.4% | $18.1M-33.8% | $18.2M-50.1% |
| Share Buybacks | $5.0Mn/m | $0n/m | $0n/m | $1.5M-57.0% | $0n/m | $0n/m | $0-100.0% | $3.5Mn/m |
NYMTN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 50.4%+21.3pp | 33.0%+59.9pp | 24.6%-14.9pp | 3.0%+29.2pp | 29.1%+124.6pp | -26.9%-68.6pp | 39.5% | -26.2%+27.4pp |
| Net Margin | 28.2%-4.2pp | 31.4%+57.9pp | 27.9%-11.6pp | 6.1%+23.2pp | 32.5%+101.5pp | -26.5%-79.7pp | 39.5% | -17.2%+29.6pp |
| Return on Equity | 3.3%+0.3pp | 3.8%+6.0pp | 3.2%+0.2pp | 0.6%+1.7pp | 3.0%+6.9pp | -2.3%-4.9pp | 3.0%+8.3pp | -1.1%+0.5pp |
| Return on Assets | 0.4%0.0pp | 0.4%+0.8pp | 0.4%-0.1pp | 0.1%+0.3pp | 0.4%+1.2pp | -0.3%-0.9pp | 0.5%+1.7pp | -0.2%+0.2pp |
| Debt-to-Equity | 0.460.0x | 0.52+0.1x | 0.55+0.1x | 0.47-0.1x | 0.47-0.2x | 0.41-0.2x | 0.48+0.1x | 0.56+0.2x |
| Liabilities-to-Equity | 7.78+1.7x | 7.86+2.3x | 7.91+2.8x | 6.63+1.9x | 6.12+2.1x | 5.60+1.9x | 5.15+1.8x | 4.72+2.0x |
| Asset Turnover | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | 21.7%+12.2pp | -7.9%-33.3pp | -9.4%+16.5pp |
Not reported in any period shown, so not listed: Gross Margin, Current Ratio.
Where NYMTN Ranks
Frequently Asked Questions
NYMTN (NYMTN) reported $601.9M in total revenue for fiscal year 2025. This represents a 50.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
NYMTN (NYMTN) revenue grew by 50.0% year-over-year, from $401.3M to $601.9M in fiscal year 2025.
Yes, NYMTN (NYMTN) reported a net income of $149.0M in fiscal year 2025, with a net profit margin of 24.8%.
NYMTN (NYMTN) had EBITDA of $160.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, NYMTN (NYMTN) had $210.3M in cash and equivalents against $735.8M in long-term debt.
NYMTN (NYMTN) had an operating margin of 22.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
NYMTN (NYMTN) had a net profit margin of 24.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
NYMTN (NYMTN) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
NYMTN (NYMTN) generated $125.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
NYMTN (NYMTN) generated $134.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
NYMTN (NYMTN) had $12.6B in total assets as of fiscal year 2025, including both current and long-term assets.
NYMTN (NYMTN) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
NYMTN (NYMTN) had a debt-to-equity ratio of 0.52 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
NYMTN (NYMTN) had a liabilities-to-equity ratio of 7.86 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
NYMTN (NYMTN) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
NYMTN (NYMTN) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
NYMTN (NYMTN) has an earnings quality ratio of 0.90x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
NYMTN (NYMTN) has an interest coverage ratio of 0.30x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.